Press room

7th March 2011
Domainex Ltd, a biotechnology company providing world-class drug discovery services to support both its own and customer research programmes, has announced plans to significantly expand its medicinal chemistry and biology capabilities in 2011.
7th January 2011
Scientists at St George’s, University of London and the University of Manchester have received an additional Seeding Drug Discovery award of £390,000 from the Wellcome Trust to explore a new class of experimental drugs that block the trigger of allergic reactions before symptoms show. Domainex will provide medicinal chemistry services and advice to support the consortium.
15th December 2010
Domainex Ltd, the leading UK-based drug discovery CRO, has won the 2010 Genesis Life Science Innovation and Enterprise Programme Of The Year Award.
1st November 2010
Domainex works with Sigma-Aldrich to advance the study of epigenetic proteins involved in cancer and stem cell biology using Combinatorial Domain Hunting CDH.
1st September 2010
Domainex Ltd announces the appointment of Dr Joanne McCudden as Head of Business Development.
1st February 2010
The two-stage funding round will bring in a significant investment from Longbow, The Capital Fund, Bury Fitzwilliam-Lay & Partners LLP, and Takeda Research Investment, Inc. (TRI).

Pages